CompletedNCT03499158Updated Apr 17, 2018

Terminal Latency Index, Residual Latency and Median Ulnar F Latency Difference in Carpal Tunnel Syndrome

An observational study in Carpal Tunnel Syndrome, sponsored by ASLIHAN UZUNKULAOGLU. Completed. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-17.

Sponsored by ASLIHAN UZUNKULAOGLU · Observational

Study type: Observational
Model: Other
Time perspective: Retrospective
Enrollment: 160
Ages: 18 Years to 90 Years
Sex: All

Study summary

Terminal latency index, residual latency and median ulnar F latency difference in carpal tunnel syndrome are specific parameters for the diagnosis

Read the detailed description

Carpal tunnel syndrome is the most common compression neuropathy. This study was performed to determine the value of terminal latency index, residual latency and median ulnar F latency difference to investigate their sensitivity and specificity in the diagnosis of this syndrome.

We retrospectively determined the 160 patients. We evaluated the nerve conduction studies of patient and healthy arms. We recorded all nerve conduction study values.

Conditions studied

Carpal Tunnel Syndrome

Browse trials for

Who can participate

Ages eligible: 18 Years to 90 Years
Sexes eligible: All
Accepts healthy volunteers: Yes
Sampling method: Probability sample

Study population

Patients who had gone to electrodiagnostic study and diagnosed as carpal tunnel syndrome

Inclusion criteria

Patients who had gone to electrodiagnostic study and diagnosed as carpal tunnel syndrome

Exclusion criteria

Exclusion Criteria:

any history of hereditary polyneuropathies
acquired polyneuropathies
surgery or local steroid injections for upper limbs or effect the study
any history of fracture at the sites of stimulation or recording

Study design

Observational model: Other
Time perspective: Retrospective
Enrollment: 160 participants (actual)
Patient registry: No

Groups and cohorts

1
affected arms of patients who had gone to electrodiagnostic study and diagnosed as carpal tunnel syndrome
Other: nerve conduction study
2
healthy arms of patients who had gone to electrodiagnostic study and diagnosed as carpal tunnel syndrome in the other arms
Other: nerve conduction study

Interventions

Othernerve conduction study
nerve conduction study

What researchers measure

Primary outcomes

nerve conduction studies
Time frame: one month

Study locations

No study locations are listed for this record.

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

Registry details

Key details

Study ID: NCT03499158
Lead sponsor: ASLIHAN UZUNKULAOGLU
Collaborators: Baskent University
Responsible party: ASLIHAN UZUNKULAOGLU (Ufuk University, Ufuk University) — Sponsor-investigator
First posted: Apr 17, 2018
Start date: Jan 1, 2016
Primary completion: Mar 1, 2016
Completion: Mar 2, 2016
Last update: Apr 17, 2018

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Carpal Tunnel Syndrome→

Start the discussion